Mounting evidence indicates that core circadian clock genes play pivotal roles in CRC oncogenesis by orchestrating the regulation of the cell cycle, epithelial-mesenchymal transition (EMT), metabolic reprogramming, and the tumor microenvironment. The gene discussed is CLOCK; the disease is neoplasm.